Filter tips for safer pipetting and better accuracy

Biohit has launched new Safetyspace Filter Tips that have more space between the sample and the filter than conventional filter tips usually have.

Relax at the After Fair

Round off the first day of the fair by visiting the After Fair. You can reload with entertainment from talented artists such as Patrik Isaksson, The Gentlemen and Ellinor Asp and take the opportunity to mingle with old and new aquaintances.

Partnering offer for scientists and medics

For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I

VTT in brief

VTT is a broad science cluster with research within applied materials, chemical and biochemical processes, energy, industrial systems management, information and communication technologies, microtechnology and electronics.

Discovery of new role for leukemia gene

Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell division in several cancers.

Anything is measurable

At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into the research of analyzing markers in body fluids.

Mingling do's and don'ts

Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, networking is about meeting and talking to people face-to-face," says mingling expert Mia Forsgren at Begriplig.

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? At the seminar Patent Strategies in the Biotech Company, you will have the chance to find out why this might not be the best idea.

Enjoy Stockholm - the capital of Scandinavia

Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and attractions. Whatever your interest might be: history, art, music or design, you can find it here!

Gabor Fischer, Distribution Sales Manager Europe, Ismatec

Why are you going to Scanlab+Biotech Forum?

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Reidar Rasmussen, Labmodul

Why are you going to Scanlab and Biotech Forum?

Per Norstedt, Regional Manager, AH Diagnostics

Why are you going to Scanlab+Biotech Forum?

Annika Garnås, LAB

Why are you going to Scanlab+Biotech Forum?

Einar Pontén, Managing Director, Merck Sequant

Why are you going to Scanlab+Biotech Forum?

Per Hammargren, Sales Director, ICU Scandinavia AB

Why are you going to Scanlab and Biotech Forum?

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be back after living in Geneva for four years. On November 10 she will take a big career leap, becoming the new CEO of Swedish Labtech.

How to get the most out of the fair

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.